Induction of hypervascularity without leakage or inflammation in transgenic mice overexpressing hypoxia-inducible factor-1α

Genes and Development

Volumn 15, Issue 19, 2001, Pages 2520-2532

  Elson, David A ^a   Thurston, Gavin ^a,d   Huang, L Eric ^e   Ginzinger, David G ^a,b   McDonald, Donald M ^a   Johnson, Randall S ^f   Arbeit, Jeffrey M ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d REGENERON PHARMACEUTICALS INC   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Angiogenesis; Epidermis; HIF 1 ; Hypoxia; Keratin; Skin

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; HYPOXIA INDUCIBLE FACTOR 1ALPHA; ISOPROTEIN; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; EDEMA; EMBRYO; EMBRYO DEVELOPMENT; ENERGY METABOLISM; EXPLANT; GENE ACTIVATION; GENE OVEREXPRESSION; HEART INFARCTION; INFLAMMATION; ISCHEMIA; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SKIN; SKIN CAPILLARY; TISSUE PERFUSION; TRANSGENIC MOUSE; VASCULARIZATION; WOUND HEALING;

ANGIOPOIETIN-1; ANGIOPOIETIN-2; ANIMALS; BASE SEQUENCE; BLOOD VESSELS; DNA PRIMERS; DNA, COMPLEMENTARY; ENDOTHELIAL GROWTH FACTORS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPHOKINES; MEMBRANE GLYCOPROTEINS; MICE; MICE, TRANSGENIC; PERMEABILITY; PROTEINS; RICIN; RNA, MESSENGER; SKIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

ANIMALIA; MUS MUSCULUS;

EID: 0035476509     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.914801     Document Type: Article

References (59)

1. Transgenic models of epidermal neoplasia and multi-stage carcinogenesis
2. Progressive squamous epithelial neoplasia in K14-human papillomavirus type 16 transgenic mice
3. Upregulation of fibroblast growth factors and their receptors during multistage epidermal carcinogenesis in K14-HPV16 transgenic mice
4. Upregulation of vascular endothelial growth factor expression induced by myocardial ischaemia: Implications for coronary angiogenesis
5. Angiogenesis in cancer and other diseases
6. Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188
7. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions
8. Vascular endothelial growth factor enhances atherosclerotic plaque progression
9. Method for the quantitative morphologic analysis of tissues
10. Mosaic blood vessels in tumors: Frequency of cancer cells in contact with flowing blood
11. Intracerebral tumor-associated hemorrhage caused by overexpression of the vascular endothelial growth factor isoforms VEGF121 and VEGF165 but not VEGF189
12. Hypoxia inducible factor-α binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein
13. Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice
14. Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis
15. Coordinate up-regulation of hypoxia inducible factor (HIF)-1α and HIF-1 target genes during multi-stage carcinogenesis and wound healing
16. Reciprocal positive regulation of hypoxia-inducible factor 1α and insulin-like growth factor 2
17. Regulation of vascular endothelial growth factor expression in cultured keratinocytes
18. De novo hair follicle morphogenesis and hair tumors in mice expressing a truncated β-catenin in skin
19. Measurement of DNA copy number at microsatellite loci using quantitative PCR analysis
20. Neuropilin-2 is a receptor for the vascular endothelial growth factor (VEGF) forms VEGF-145 and VEGF-165
21. Isoforms of vascular endothelial growth factor act in a coordinate fashion to recruit and expand tumor vasculature
22. Openings between defective endothelial cells explain tumor vessel leakiness
23. 2-dependent degradation domain via the ubiquitin-proteasome pathway
24. Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells
25. 2 sensing
26. 2 homeostasis by hypoxia-inducible factor 1α
27. 2-regulated proprolyl hydroxylation
28. 2 tension
29. Hypoxia activates jun-N-terminal kinase, extracellular signal-regulated protein kinase, and p38 kinase in pulmonary arteries
30. VEGF/VPF overexpression in skin of transgenic mice induces angiogenesis, vascular hyperpermeability and accelerated tumor development
31. Expression of vascular endothelial growth factor mRNA following transient forebrain ischemia in rats
32. VEGF gene delivery to myocardium: Deleterious effects of unregulated expression
33. Early expression of angiogenesis factors in acute myocardial ischemia and infarction
34. Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia
35. Hypoxia-inducible protein binding to vascular endothelial growth factor mRNA and its modulation by the von Hippel-Lindau protein
36. Post-transcriptional regulation of vascular endothelial growth factor by hypoxia
37. Sequencing of the human vascular endothelial growth factor (VEGF) 3′ untranslated region (UTR): Conservation of five hypoxia-inducible RNA-protein binding sites
38. PR39, a peptide regulator of angiogenesis
39. Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization
40. Differences in myocardial and peripheral VEGF and KDR levels after acute ischemia
41. Overexpression of activin A in the skin of transgenic mice reveals new activities of activin in epidermal morphogenesis, dermal fibrosis and wound repair
42. Differential expression of VEGF isoforms in mouse during development and in the adult
43. Hypoxia and vascular endothelial growth factor selectively up-regulate angiopoietin-2 in bovine microvascular endothelial cells
44. Ubiquitination of hypoxia-inducible factor requires direct binding to the β-domain of the von Hippel-Lindau protein
45. Reversible activation of c-Myc in skin: Induction of a complex neoplastic phenotype by a single oncogenic lesion
46. Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF
47. HIF-1α is required for solid tumor formation and embryonic vascularization
48. 2 homeostasis by hypoxia-inducible factor 1
49. Hypoxia, clonal selection, and the role of HIF-1 in tumor progression
50. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor
51. VEGF gene delivery to muscle: Potential role for vasculogenesis in adults
52. Translation of vascular endothelial growth factor mRNA by internal ribosome entry: Implications for translation under hypoxia
53. Increased vascularization in mice overexpressing angiopoietin-1
54. Permeability-related changes revealed at endothelial cell borders in inflamed venules by lectin binding
55. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1
56. Comparative expression of novel vascular endothelial growth factor/vascular permeability factor transcripts in skin, papillomas, and carcinomas of v-Has-ras TgAC transgenic mice and FVB/n mice
57. Angiogenesis is induced in a rabbit model of hindlimb ischemia by naked DNA encoding an HIF-1a/VP16 hybrid transcription factor
58. Mammalian oxygen sensing, signaling and gene regulation
59. Increased expression of hypoxia inducible factor-1α in rat and human prostate cancer